63 pages •
By Infiniti Research Limited
• Jun 2017
The offers a wide range of devices and kits for autoimmune diseases worldwide.
539 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
543 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
545 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
564 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
546 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
552 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
552 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
547 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
544 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
547 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
35 pages •
By GlobalData
• Feb 2018
- Apr 20, 2017: Immunovia Interim report, January-March 2017
- IMMUNOVIA ENTERS INTO AGREEMENT FOR IMMRAY
Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease progression, and monitoring...
31 pages •
By GlobalData
• Apr 2018
- Apr 20, 2017: Immunovia Interim report, January-March 2017
- Deal Type
Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer.The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease progression, and monitoring...
590 pages •
By GlobalData
• May 2017
NESTLE WILL LEAD SANOFI S RESEARCH EFFORTS TO BUILD A ROBUST AND INNOVATIVE EARLY PORTFOLIO IN IMMUNOLOGY AND INFLAMMATION, HELPING THE COMPANY ACHIEVE A LEADERSHIP POSITION IN CRITICAL AREAS SUCH AS CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASE.
120 pages •
By Global Markets Direct
• Jun 2016
It focuses on therapy areas such as respiratory, inflammation, autoimmune disease (RIA); cardiovascular and metabolic disease (CVMD); and cancer, besides infection and neurological diseases.
582 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
650 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
179 pages •
By Global Markets Direct
• Jun 2017
Plexxikon announced in January that enrollment started for the first of two Phase ## clinical trials with PLX##, a novel, oral, targeted and highly selective Fms kinase inhibitor for the treatment of autoimmune diseases such as RA.
100 pages •
By Global Markets Direct
• Aug 2017
- RECOMBINANT PROTEIN TO ANTAGONIZE CXCR4 FOR ONCOLOGY - DRUG PROFILE
Lilly also has mid-tolate stage pipeline portfolio for conditions such as diabetes, cancer, neurological problems and autoimmune disorders.
123 pages •
By Global Markets Direct
• Nov 2016
IT FOCUSES ON THERAPY AREAS SUCH AS RESPIRATORY, INFLAMMATION, AUTOIMMUNE DISEASE (RIA); CARDIOVASCULAR AND METABOLIC DISEASE (CVMD); AND CANCER, BESIDES INFECTION AND NEUROLOGICAL DISEASES.
104 pages •
By Global Markets Direct
• Feb 2018
Lilly also has mid-tolate stage pipeline portfolio for conditions such as diabetes, cancer, neurological problems and autoimmune disorders.
48 pages •
By Global Markets Direct
• Apr 2016
The company' s offer products in autoimmune disease, oncology, diabetes, pain.
342 pages •
By GlobalData
• Nov 2015
Teva manufactures specialty pharmaceuticals for the treatment of disorders such as multiple sclerosis, Parkinson' s disease, autoimmune diseases, cancer and pain management.
108 pages •
By Global Markets Direct
• Oct 2016
THE INVENTION RELATES TO NOVEL CXCL##-Α## LOCKED DIMER POLYPEPTIDE, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING DIMER IN THE TREATMENT OF CANCER AND AUTOIMMUNE, INFLAMMATORY DISEASE AND HIV/ AIDS.
107 pages •
By GlobalData
• Oct 2015
- MK PAN CANCER MARKER ASSAY - PRODUCT STATUS
- MK PAN CANCER MARKER ASSAY - PRODUCT DESCRIPTION
The company' s products are used for the treatment and detection of cancers, the treatment of inflammatory, autoimmune diseases, and ischemic heart disease.
54 pages •
By Global Markets Direct
• Sep 2015
(Merrimack) is a biopharmaceutical company that discovers, develops and provides therapies for the treatment of autoimmune disease and cancer.